Introduction {#j_hukin-2017-0090_s_001}
============

Numerous studies have shown that intense physical activity is essential for health and helps prevent hypertension, atherosclerosis ([@j_hukin-2017-0090_ref_025]) and diabetes ([@j_hukin-2017-0090_ref_024]). The level of physical activity which allows to improve basic biochemical variables such as insulin, lipids or glucose depends on many factors and should be personalised ([@j_hukin-2017-0090_ref_031]; [@j_hukin-2017-0090_ref_034]; [@j_hukin-2017-0090_ref_008]). Some of the athletes who end their professional career, especially those of international level, remain physically active and lead a healthy lifestyle. The risk of acquiring the metabolic syndrome or cardiovascular disease is much lower for them than for the general population; however, most studies on former athletes focus on elite players ([@j_hukin-2017-0090_ref_004]; [@j_hukin-2017-0090_ref_027]; [@j_hukin-2017-0090_ref_037]; [@j_hukin-2017-0090_ref_032]).

There are only few studies which show the condition of former athletes who achieved success at a local or national level. Many former athletes reduce their physical activity and do not change their dietary habits. It causes difficulties in maintaining normal body mass and may lead to obesity, diabetes and many other diseases. A study conducted on a group of 100 former soccer players from Brazil showed that 78% of them were overweight and 4% suffered from obesity ([@j_hukin-2017-0090_ref_002]).

The generally recommended diet associated with a decreased risk of cardiovascular disease, cancer and obesity is the Mediterranean diet (MD) ([@j_hukin-2017-0090_ref_003]). It has been shown that this type of diet can be recommended to all populations worldwide ([@j_hukin-2017-0090_ref_026]). The beneficial effect of the MD is based on various mechanisms associated with increased supply of dietary components such as vitamins, antioxidants, monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA). The MD also includes increased amounts of fish, whole grain products, vegetables, fruits and nuts. The main source of fat in MD is olive oil, which provides most of the energy coming from fat ([@j_hukin-2017-0090_ref_011]).

Another nutritional approach that allows to achieve many health benefits and extends a lifespan is the calorie restriction diet (CR). The diet is based on a 20-30% calorie cut from the basic metabolic rate. Despite the restriction, the CR diet should provide all of the nutrients needed for proper body functioning ([@j_hukin-2017-0090_ref_030]). Scientific research has shown that this type of diet helps improve insulin resistance, hypertension, obesity, and basic biochemical variables. The CR diet has a significant impact on gene expression, particularly genes related to the skeletal muscle metabolism, brain and heart muscle ([@j_hukin-2017-0090_ref_017]). However, there is little data about the type and effectiveness of the diet among former athletes. Therefore, it seems important to search for optimal nutrition for this population.

The Mediterranean diet has a significant impact on the improvement of lipid variables and insulin resistance, therefore it has cardiovascular protective effects. Some of these effects are caused by an increased intake of unsaturated fatty acids. Research has shown that the Mediterranean diet can improve the fatty acid profile in the serum and help reduce inflammation ([@j_hukin-2017-0090_ref_015]). A one year dietary intervention based on the Mediterranean diet in patients with rheumatoid arthritis improved EPA and DHA in the serum phospholipid. This research confirmed that these changes contributed to prevention of inflammation ([@j_hukin-2017-0090_ref_001]). A study conducted on the Swedish population showed that even short term Mediterranean diet (4 weeks) could improve serum fatty acid concentration related to omega 3 and omega 6 families ([@j_hukin-2017-0090_ref_036]). Research based on the Mediterranean population reveals that cardiovascular events in this group are less frequent than in other populations. Furthermore, due to the high consumption of sea-food and fish, the omega -- 3 index (the sum of eicosapentaenoic acid and docosahexaenoic acid) is higher in this group in comparison to the American population ([@j_hukin-2017-0090_ref_010]). The high intake of EPA and DHA could, in part, explain the paradox of low rates of both cardiovascular events and cardiac death, despite a high background prevalence of cardiovascular risk factors ([@j_hukin-2017-0090_ref_006]).

We already know that some fatty acids such as linoleic acid (LA) and arachidonic acid (AA) can be transformed into immunomodulators, i.e., prostaglandins, leukotrienes, thromboxanes, and hydroxyeicosatetraenoic and hydroxyoctadecadienoic acids (HETE and HODE, respectively). Both EPA and DHA are the source of anti-inflammatory mediators while AA derivatives are strongly pro-inflammatory. EPA competes with AA for the same enzymes, therefore a higher level of EPA can reduce the level of AA products and inflammation. One of the most powerful inflammatory mediators are HETE and HODE. They are involved in many inflammation processes such as neutrophils and macrophages regulation, endothelial cells adhesion, reorganization of the cytoskeleton and production of cytokines ([@j_hukin-2017-0090_ref_035]).

The fatty acid profile as well as the eicosanoids profile can provide essential knowledge about diet, however, there is little data about fatty acids or their derivatives' status during the calorie restriction diet.

The aim of the study was to investigate the effects of 6 week Mediterranean diet or 30% calorie restriction on the fatty acid profile and eicosanoids (hydroxyoctadecadienoi acids and hydroxyeicosatetraenoic acids) concentration. Furthermore, basic biochemical variables such as insulin, glucose, HOMA-IR and lipid profile were estimated.

Methods {#j_hukin-2017-0090_s_002}
=======

Subjects {#j_hukin-2017-0090_s_002_s_001}
--------

The study enrolled 94 Caucasian former athletes aged 20-42, with body height of 179 ± 16.00 cm and body mass of 89.26 ± 13.25 kg, who had not been active for at least 5 years. The study participants represented the following sport disciplines: canoeing, rowing, swimming, athletics, soccer, and different strength sports. The subjects were randomly assigned to one of the three intervention groups: CR group - calorie restriction (n = 32), MD group - Mediterranean diet (n = 34), and C group -- a control group (n = 28). In the CR and MD groups, the subjects consumed daily less than 30% of their Total Daily Energy Expenditure (TDEE). Former athletes who suffered from celiac disease, hypertension, hypercholesterolemia or glucose intolerance were excluded from the study. The study protocol was approved by the ethics committee of the Pomeranian Medical University and conformed to the ethical guidelines of the 1975 Declaration of Helsinki. After the 6 week dietary intervention, 36 subjects were excluded from the study because they followed the diet in less than 30% ([Figure 1](#j_hukin-2017-0090_fig_001){ref-type="fig"}).

![Classification into groups depending on body mass reduction.](hukin-60-063-g001){#j_hukin-2017-0090_fig_001}

Dietary intervention {#j_hukin-2017-0090_s_002_s_002}
--------------------

The subjects were randomly divided into the CR, MD or C group during the first visit to the laboratory ([Figure 1](#j_hukin-2017-0090_fig_001){ref-type="fig"}). The diet was programmed individually for each subject according to his/her caloric needsby a certificated nutritionist. Total daily energy expenditure (TDEE) was calculated using the direct measurement of the resting metabolic rate (RMR) that was measured twice, i.e., during the first and control visit, with a Fitmate apparatus (Pro, COSMED Italy). The activity factor (AF) was calculated using the standard formula (TDEE = AF x RMR). Subjects in the CR and MD groups with a BMI indicating overweight or obesity (BMI over 25 kg/m^2^) received a reduced calorie diet of 30% of their TDEE. Caloric restriction was established by reducing the diet by 30% considering the resting metabolic rate (RMR) ([Table 1](#j_hukin-2017-0090_tab_001){ref-type="table"}). The control group was not submitted to any type of diet. All individuals received a weekly dietary plan and guidelines on the composition and size of portions as well the times of meals throughout the day. The menu was prepared in the form of five daily meals, for seven days of the week. The recommended source of fat in all groups was olive oil. Animal fats such as lard were excluded, while usage of butter and margarine was permissible. The recommended source of carbohydrates included whole wheat bread, whole-wheat pasta, cereal and brown rice. Sweets were excluded. The recommended protein source comprised poultry, fish, fermented dairy products, eggs, lean cottage cheese, cheese with reduced fat content. Fat meat and other high fat products were excluded. Three daily portions of vegetables and two portions of fruit were recommended in the diets. The amount of fluid intake was calculated as 35 ml/kg of actual body mass per day. The details of particular diets are presented in [Table 1](#j_hukin-2017-0090_tab_001){ref-type="table"}.

###### 

Diet specification

  Diet type              Mediterranean diet   CR diet
  ---------------------- -------------------- --------------------------
  **Protein**            1g/kg body mass      1g/kg body mass
  **Fats**:              25-35% of TDEE       \<20% of TDEE
                                              
  **SFA**                \<7%                 \<10%
  **MUFA**               \>60%                \>50%
  **PUFA**               \>20-35%             \>20-35%
  **Cholesterol**        300 mg/day           300 mg/day
  **Carbohydrates**      50-60% from TDEE     50-60% from TDEE
  **Simple sugars**      \<10% from TDEE      \<10% from TDEE
  **Fibre**              30-35 g/day          30-35 g/day
  **Fish consumption**   3 times/week         2 times/week
  **Snacks**             Fruit and nuts       Fruit and natural yogurt

Dietary control {#j_hukin-2017-0090_s_002_s_003}
---------------

After the 6 week intervention, all participants were evaluated for fatty acid content and their derivatives' (eicosanoids) profiles, as well as basic anthropometric and biochemical variables. The pattern of nutrition was analysed using the 72 h food diary (including two working days and one weekend day) during the visits to the laboratory. The amount of food consumed was recorded in household units, by volume or by measuring with a ruler. The dietary records were validated by a nutritionist on the basis of the corresponding food table and the nutrient database.

Biochemical blood analysis {#j_hukin-2017-0090_s_002_s_004}
--------------------------

*After an overnight fast*, venous blood was collected and placed in tubes with anticoagulant for lipid analyses. Whole blood was collected and placed in ethylenediaminetetraacetic acid (EDTA) tubes. Blood was immediately placed on ice or in a refrigerator, and the samples were centrifuged at 3500 rpm for 10 min at 4°C within 2 h of collection. Plasma was then immediately stored under conditions to minimize artificial oxidation (i.e., with an antioxidant cocktail in an inert atmosphere). Standard blood biochemical analyses were carried out at the University Hospital Laboratory.

Isolation of fatty acids and analysis of fatty acid esters {#j_hukin-2017-0090_s_002_s_005}
----------------------------------------------------------

Plasma was obtained from blood (taken at blood clot) by centrifugation for 10 min at 1200 G. Fatty acids were extracted with chloroform/methanol solution. About 0.5 ml of plasma was saponified with 1 ml of 2M KOH methanolic solution at 70°C for 20 min and then methylated with 2 ml of 14% solution of boron trifluoride in methanol under the same conditions. Then 2 ml of n-hexane and 10 ml saturated NaCl solution were added. 1 ml of the n-hexane phase was collected for analysis.

Gas chromatography was performed using an Agilent Technologies 7890A GC System (SUPELCOWAX™ 10 Capillary GC Column (15 m × 0.10 mm, 0.10 μm), Supelco, Bellefonte, PA, USA). Chromatographic conditions were as follows: the initial temperature was 60°C for 0 min, increased at the rate of 40°C/min to 160°C (0 min), then increased at the rate of 30°C/min to 190°C (0.5 min) and finally increased at the rate of 30°C/min to 230°C for 2.6 min, where it was maintained for 4.9 min. The total analysis lasted approximately 8 min and the gas flow rate was 0.8 ml/min with hydrogen as the carrier gas. Fatty acids were identified by comparing their retention times with those of commercially available standards.

Isolation and analyses of fatty acid derivatives {#j_hukin-2017-0090_s_002_s_006}
------------------------------------------------

5(S),6(R)-Lipoxin A~4~, 5(S),6(R), 15(R)- Lipoxin A~4~, 5(S)-HETE, 5(S)-oxoETE, 12(S)-HETE, 15(S)-HETE, 16(R)/16(S)-HETE, 9(S)-HODE and 13(S)-HODE were extracted from the 0.5 ml of plasma by using a solid-phase extraction RP-18 SPE columns (Agilent Technologies, UK).

The HPLC separations were performed using Agilent Technologies 1260 liquid chromatography. Agilent ChemStation software (Agilent Technologies, Cheadle, UK) was employed for instrument control, data acquisition and analysis. The separation was completed on a Thermo Scientific Hypersil BDS C18 column 100x4.6mm 3μm (cat no. 28103-104630). The temperature of the column oven was set at 25°C. A gradient method was used where the mobile phase was composed of a mixture of solvent A (methanol/water/acetic acid, 50/50/0.1, v/v/v) and B (methanol/water/acetic acid, 100/0/0.1, v/v/v). The content of buffer B in the mobile phase was 30% at 0.0 min of separation, then it increased linearly to 80% at 20 min, was 98% between 20.1 and 23.9 min, and 30% between 24 and 28 min. The flow rate was 1.0 mL/min. The sample injection volume was 60 uL. The absorbance spectra of peaks were analysed to confirm the identification of analytes. The quantification was based on peak areas with internal standard calibration.

Statistical analysis {#j_hukin-2017-0090_s_002_s_007}
--------------------

Statistica 7.1 software was used for the statistical analysis and the results are expressed as mean ± standard deviation. As distribution in most cases was normal (Shapiro-Wilk test), parametric tests were used: a t test for comparisons between groups, and *p* \< 0.05 was considered as statistically significant.

Results {#j_hukin-2017-0090_s_003}
=======

Thirty-six subjects were excluded from the study because they followed the diet in less than 30% or did not attend the control visit. Subjects who completed the experiment (n = 58) were analysed according to groups: MD, CR or C, and there were no significant differences between biochemical variables. Therefore we rearranged the groups and classified them depending on body mass reduction (\>1.5 kg, \>2.5 kg, \>3 kg). Division into particular groups corresponded to the percentage of the completion of the dietary plan. The classification is shown in [Table 2](#j_hukin-2017-0090_tab_002){ref-type="table"} and [Figure 1](#j_hukin-2017-0090_fig_001){ref-type="fig"}.

###### 

Subject classification

  6 weeks = 42 days of diet                                                                             
  ----------------------------- ----------------------------------------------------------------------- --------------------------------------------------------------------
  Mean (SD) of calorie amount   2173 (231) kcal                                                         2293 (269) kcal
  \> 1.5 kg                     \>31.25%[^\#^](#j_hukin-2017-0090_fn_001){ref-type="table-fn"} n = 15   \>50%[^\#^](#j_hukin-2017-0090_fn_001){ref-type="table-fn"} n = 15
  \> 2.5 kg                     \>52%[^\#^](#j_hukin-2017-0090_fn_001){ref-type="table-fn"} n = 10      \>83%[^\#^](#j_hukin-2017-0090_fn_001){ref-type="table-fn"} n = 11
  \> 3 kg                       \>62.5%[^\#^](#j_hukin-2017-0090_fn_001){ref-type="table-fn"} n = 7     100%[^\#^](#j_hukin-2017-0090_fn_001){ref-type="table-fn"} n = 8

The percentages of completion of a dietary plan

Biochemical variables, fatty acid and eicosanoid profiles were evaluated in the blood before and after the 6 week dietary intervention. The results showed that the following biochemical variables were significantly reduced in the CR group: LDL-cholesterol, triacylglycerols and total lipids. These results were observed at the lowest level of body mass reduction (\>1.5 kg). In the case of \> 3 kg reduction, we also observed an improvement in insulin and HOMA-IR levels. The MD group showed significantly lower concentration of total lipids, but only at the level of the reduction \> 3 kg. We did not notice significant changes in the control group. The results of biochemical variables are shown in [Table 3](#j_hukin-2017-0090_tab_003){ref-type="table"}.

###### 

Biochemical variables of subjects from the CR and MD groups

  Variables                           CR group                                                                                                                                        MD group                                                               
  ----------------------------------- ----------------------------------------------------------------------- ----------------------------------------------------------------------- ---------------------------------------------------------------------- -------------------------------------------------------------------------
  Body mass index (BMI) \[kg/m^2^\]   **28.5 (1.25)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}   **27 (1.05)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}     **28.8 (8.5)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}   **28.15 (14.15)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}
  Total cholesterol \[mg/dl\]         203 (36)                                                                175 (20)                                                                186 (39.5)                                                             172 (36.7)
  HDL-cholesterol \[mg/dl\]           51 (11.5)                                                               46 (12.3)                                                               51 (16)                                                                44.5 (25.5)
  LDL - cholesterol \[mg/dl\]         **120 (30.5)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    **107 (24)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}      120 (42.75)                                                            105 (32.25)
  Triacylglycerols \[mg/dl\]          **176 (35.6)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    **165 (26)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}      104 (62.5)                                                             74.5 (65.5)
  Fasting glucose \[mg/ml\]           95 (33)                                                                 97 (29)                                                                 99 (66)                                                                95 (35.5)
  Fasting insulin \[U/ml\]            7.5 (4.2)                                                               6 (3.8)                                                                 8 (3.2)                                                                7.7 (4.9)
  HOMA-IR                             1.88 (0.56)                                                             1.85 (0.51)                                                             2.35 (2.16)                                                            1.77 (1.37)
  **Reduction \> 2.5 kg**             **CR group**                                                                                                                                    **MD group**                                                           
                                                                                                                                                                                                                                                             
  Body mass index (BMI) \[kg/m^2^\]   **30 (4.2)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}      **28.3 (3.9)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    **30.6 (4.3)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}   **29.7 (4)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}
  Total cholesterol \[mg/dl\]         **183 (16.2)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    **165 (19.5)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    200 (51.7)                                                             192 (60)
  HDL-cholesterol \[mg/dl\]           50 (14.7)                                                               48.8 (13.4)                                                             46.4 (14.4)                                                            47.7 (15.8)
  LDL - cholesterol \[mg/dl\]         **109 (95.9)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    **99.9 (15.4)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}   139 (90)                                                               143 (107.2)
  Triacyloglycerols \[mg/dl\]         **122 (96.6)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    **82.6 (48.4)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}   247 (72)                                                               244 (46)
  Fasting glucose \[mg/ml\]           97 (5.8)                                                                92.1 (7)                                                                99 (8.1)                                                               96.1 (10.6)
  Fasting insulin \[U/ml\]            11 (7.1)                                                                10.2 (6.4)                                                              13.5 (7.35)                                                            13.8 (9.7)
  HOMA-IR                             **3 (1.8)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}       **2.4 (1.6)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}     3.36 (1.9)                                                             2.17 (1.41)
  **Reduction \> 3 kg**               **CR group**                                                                                                                                    **MD group**                                                           
                                                                                                                                                                                                                                                             
  Body mass index (BMI) \[kg/m^2^\]   **32 (5.4)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}      **31 (5.1)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}      **30 (4.2)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}     **28.3 (3.9)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}
  Total cholesterol \[mg/dl\]         **207 (29)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}      **178 (8.4)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}     183 (16.2)                                                             165 (19.5)
  HDL-cholesterol \[mg/dl\]           50 (9.3)                                                                51 (13.6)                                                               50 (14.7)                                                              48.8 (13.4)
  LDL - cholesterol \[mg/dl\]         **135 (28.9)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    **112 (14.5)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    109 (25.9)                                                             25.9 (48.4)
  Triacylglycerols \[mg/dl\]          **109 (56.1)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}    **74 (26.3)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}     122 (48)                                                               82.6 (126)
  Fasting glucose \[mg/ml\]           94 (9.3)                                                                99 (5.3)                                                                97 (5.8)                                                               92.1 (7)
  Fasting insulin \[U/ml\]            **15 (11.8)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}     **10 (5.7)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}      11 (7.1)                                                               10.2 (6.4)
  HOMA-IR                             **4 (3.1)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}       **2 (1.5)**[^\*^](#j_hukin-2017-0090_fn_007){ref-type="table-fn"}       2.35 (2.1)                                                             1.77 (1.37)

*p* \< 0.05

Analysis of the fatty acid profile showed significant changes in the concentration of polyunsaturated fatty acids. In both the CR and MD groups, an over 1.5 kg reduction did not reveal any changes. The CR group showed a significantly lower level of gamma-linoleic acid (GLA) and eicosapentaenoic acid (EPA). Subjects that followed the MD had significantly higher concentrations of docosahexaenoic acid (DHA). We did not observe any changes in the control group. The fatty acids profile is shown in [Table 4](#j_hukin-2017-0090_tab_004){ref-type="table"}. On the basis of changes in the fatty acid profile, the basic biomarker of coronary heart disease was calculated ([@j_hukin-2017-0090_ref_016]; [@j_hukin-2017-0090_ref_020]; [@j_hukin-2017-0090_ref_021]). Regardless of the body mass reduction, both the control and CR group did not show any significant changes. Regarding the omega -- 3 index, we observed an improvement in the MD group. This trend was found in subjects with the mass reduction of \>2.5 kg and \>3 kg ([Table 4](#j_hukin-2017-0090_tab_004){ref-type="table"}).

###### 

Fatty acid profile

                                          CR group                                                         MD group                                                                                                                                                                                                                                
  --------------------------------------- ---------------------------------------------------------------- -------------- ---------------------------------------------------------------- ---------- ---------------------------------------------------------------- ---------- ---------------------------------------------------------------- ----------
  C14:0 myristic acid                     5.58                                                             2.12           4.61                                                             1.94       6.29                                                             5.29       7.23                                                             9.74
  C14:1 miristoleic acid                  2.11                                                             0.79           1.85                                                             0.42       1.76                                                             0.60       2.13                                                             0.72
  C15:0 pentadecanoic acid                0.73                                                             0.47           0.59                                                             0.58       0.73                                                             0.79       0.99                                                             1.35
  C16:0 palmitic acid                     192.45                                                           98.86          147.82                                                           62.64      155.94                                                           96.75      211.39                                                           211.72
  C16:1 palmitoleic acid                  4.10                                                             1.76           2.61                                                             0.91       5.11                                                             5.98       7.09                                                             12.60
  C17:0 heptadecanoic acid                1.13                                                             5.70           1.13                                                             0.27       0.99                                                             0.61       1.27                                                             1.25
  C18:0 stearic acid                      135.96                                                           77.87          108.49                                                           57.28      94.07                                                            43.30      120.32                                                           64.75
  C18:1w9 oleic acid                      26.92                                                            17.50          18.88                                                            7.02       28.78                                                            28.88      44.23                                                            77.38
  C18:1trans11 trans-vaccenic acid        4.23                                                             2.21           2.98                                                             1.38       3.82                                                             3.11       5.72                                                             7.11
  C18:2n-6 linoleic acid                  68.39                                                            43.91          51.14                                                            21.43      49.10                                                            31.22      74.15                                                            97.69
  C18:3n-6 gamma-linolenic acid           **0.80**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **0.36**       **0.55**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **0.32**   0.82                                                             0.39       1.03                                                             1.42
  C18:3n-3 linolenic acid                 2.32                                                             2.11           1.73                                                             0.54       2.41                                                             1.65       3.84                                                             6.83
  C20:4 n-6 arachidonic acid              19.51                                                            10.25          14.94                                                            6.29       13.62                                                            6.39       19.58                                                            15.59
  C20:5 n-3 eicosapentaenoic acid (EPA)   **1.46**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **1.05**       **0.85**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **0.33**   0.81                                                             0.56       1.12                                                             0.78
  C22:6 n-3 docosahexaenoic acid (DHA)    9.23                                                             5.60           7.15                                                             2.33       **5.71**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **3.73**   **8.95**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **6.65**
  Omega 3 index (EPA+DHA)                 9.89                                                             3.58           8.10                                                             2.83       **7.18**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **4.43**   **9.24**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **7.26**
  **Reduction \>3 kg**                    **CR group**                                                     **MD group**                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                   
  C10:0 Lauric acid                       4.29                                                             1.45           4.37                                                             1.55       3.69                                                             1.26       3.66                                                             0.53
  C14:0 myristic acid                     4.76                                                             0.51           4.79                                                             2.31       4.89                                                             1.96       4.17                                                             1.43
  C14:1 miristoleic acid                  1.73                                                             0.18           2.00                                                             0.51       1.55                                                             0.41       1.84                                                             0.21
  C15:0 pentadecanoic acid                0.47                                                             0.36           0.59                                                             0.62       0.59                                                             0.50       0.56                                                             0.33
  C16:0 palmitic acid                     142.61                                                           25.87          153.59                                                           70.76      141.59                                                           51.09      148.71                                                           30.53
  C16:1 palmitoleic acid                  3.39                                                             0.94           3.29                                                             1.42       3.63                                                             2.01       3.00                                                             1.33
  C17:0 heptadecanoic acid                1.00                                                             0.31           1.17                                                             0.32       0.93                                                             0.26       0.88                                                             0.35
  C18:0 stearic acid                      99.50                                                            27.72          111.85                                                           62.07      97.14                                                            37.39      108.62                                                           28.73
  C18:1w9 oleic acid                      20.66                                                            3.71           20.62                                                            7.96       23.16                                                            12.69      19.53                                                            4.92
  C18:1trans11 trans-vaccenic acid        3.34                                                             0.41           3.06                                                             1.67       3.28                                                             1.37       3.27                                                             0.81
  C18:2n-6 linoleic acid                  47.69                                                            7.63           50.13                                                            23.93      47.43                                                            19.46      41.71                                                            9.93
  C18:3n-6 gamma-linolenic acid           **0.80**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **0.09**       **0.59**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **0.29**   0.77                                                             0.22       0.64                                                             0.30
  C18:3n-3 linolenic acid                 1.82                                                             0.29           1.81                                                             0.50       2.18                                                             1.06       1.65                                                             0.24
  C20:4 n-6 arachidonic acid              16.08                                                            2.44           16.57                                                            6.50       13.40                                                            2.75       14.23                                                            3.27
  C20:5 n-3 eicosapentaenoic acid (EPA)   **1.16**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **0.50**       **0.78**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **0.31**   0.85                                                             0.48       0.98                                                             0.30
  C22:6 n-3 docosahexaenoic acid (DHA)    7.13                                                             1.84           6.40                                                             1.90       **5.58**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **2.74**   **6.84**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **2.26**
  Omega 3 index (EPA+DHA)                 8.30                                                             2.31           7.19                                                             2.15       **7.09**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **3.93**   **7.95**[^\*^](#j_hukin-2017-0090_fn_041){ref-type="table-fn"}   **2.64**

*p* \< 0.05

The main eicosanoids (fatty acid derivatives) were measured in the serum of each subject. The reductions of body mass of \>1.5 kg and \>2.5 kg did not induce any changes in any of the groups. The subjects from the MD group who lost over 3 kg reduced the level of 15- hydroxyeicosatetraenoic acid (15 -- HETE). We did not observe any differences in the control and CR groups. [Table 5](#j_hukin-2017-0090_tab_005){ref-type="table"} shows the eicosanoids profile.

###### 

Eicosanoids profile

               CR group   MD group                                                                                                                                                                   
  ------------ ---------- ---------- ------- ------- ----------------------------------------------------------------- ----------- ----------------------------------------------------------------- -----------
  LTX5S6R15R   0.087      0.091      0.07    0.083   0.16                                                              0.129       0.12                                                              0.148
  16RS-HETE    0.001      0.001      0.001   0.001   0.001                                                             0.001       0.001                                                             0.001
  13S-HODE     0.012      0.017      0.007   0.01    0.015                                                             0.012       0.015                                                             0.017
  9S-HODE      0.045      0.054      0.023   0.031   0.048                                                             0.037       0.042                                                             0.049
  15S-HETE     0.068      0.064      0.04    0.049   **0.102**[^\*^](#j_hukin-2017-0090_fn_057){ref-type="table-fn"}   **0.067**   **0.051**[^\*^](#j_hukin-2017-0090_fn_057){ref-type="table-fn"}   **0.054**
  12S-HETE     0.265      0.267      0.157   0.172   0.378                                                             0.301       0.191                                                             0.23
  5-oxo-ETE    0.015      0.018      0.01    0.011   0.016                                                             0.014       0.015                                                             0.016

*p*\<0.05

Discussion {#j_hukin-2017-0090_s_004}
==========

Former athletes constitute a specific population as previous intense physical activity has significantly changed their metabolism, yet little is known about the consequences of these changes after the end of their sports carriers. There are no dietary recommendations for this population. Our study examined the effects of two types of diets on former athletes. One of the diets was based on a 30% calorie restriction, while the other was the Mediterranean diet containing increased amounts of monounsaturated fatty acids (MUFA, from olive oil). The difference between the MD and CR groups was also in their total fat consumption. The diet intervention was relatively short and lasted 6 weeks (42 days). The evaluation of the effectiveness of a diet usually starts with basic anthropometric measurements, including calculation of the BMI. The next step consists of the analysis of basic biochemical variables such as the lipid profile, fasting glucose and insulin level. These simple variables allow to assess the general condition of subjects, the risk of common diseases, and the effectiveness of dietary intervention ([@j_hukin-2017-0090_ref_019]).

Based on the results of biochemical tests and body mass reduction, it can be concluded that the calorie restriction is more appropriate for subjects with dyslipidemia or insulin resistance. It should be highlighted that even a modest body mass reduction of 1.5 kg significantly improves the bloods' lipid profile, while such changes are not observed in case of the MD ([@j_hukin-2017-0090_ref_012]).

Body mass reduction in the CR group of more than 3 kg helped improve the lipid profile and normalized the level of insulin and insulin resistance in subjects who completed more than 60% of the established dietary plan. Recent studies confirm that caloric restriction helps reduce insulin resistance and insulin levels. This relationship was observed even in former athletes who did not exercise ([@j_hukin-2017-0090_ref_028]).

In the MD group, most of the biochemical variables did not change significantly ([Table 3](#j_hukin-2017-0090_tab_003){ref-type="table"}, [Figure 2](#j_hukin-2017-0090_fig_002){ref-type="fig"}). Only in the subgroup with a reduction of more than 3 kg we registered a lower concentration of total lipids, yet the other lipid variables and insulin resistance did not improve significantly. The lack of changes in biochemical variables can be caused by a relatively short time of the dietary intervention.[@j_hukin-2017-0090_ref_014] showed that even short-term application of the Mediterranean diet (4 weeks) improved insulin resistance and reduced insulin secretion. The authors of that study also established significant calorie restrictions, with the total amount of calorie intake ranging from 1400 to 1600 kcal/day. In our experiment, the average energy intake was 2293 kcal (SD = 269) ([@j_hukin-2017-0090_ref_014]). Considering the results of other studies and our observations, we can conclude that a high calorie restriction is the major factor in improving the lipid profile and insulin sensitivity. Yet, the mechanism of insulin secretion during calorie restriction is not fully understood. It is known that the improvement is associated with a decreased amount of free fatty acids circulating in the blood and cytokines released by adipose tissue ([@j_hukin-2017-0090_ref_005]; [@j_hukin-2017-0090_ref_022]). Calorie restriction also increases the glucose infusion rate which helps maintain a proper level of glucose during hyperinsulinemia and results in increased peripheral insulin sensitivity ([@j_hukin-2017-0090_ref_023]).

![Effects of the MD and CR diets on the lipid profile](hukin-60-063-g002){#j_hukin-2017-0090_fig_002}

Analysis of the fatty acid profile revealed that subjects consuming the MD had a significantly higher level of DHA after the dietary intervention, whereas the CR group showed significantly lower concentrations of EPA and GLA. Both EPA and DHA are very important in the human diet as they regulate many essential metabolic processes, gene expression and build cell membranes in body structures ([@j_hukin-2017-0090_ref_007]; [@j_hukin-2017-0090_ref_029]; [@j_hukin-2017-0090_ref_038]). One of the most important roles of EPA and DHA includes the regulation of inflammatory processes. Enzymatic products of these acids help suppress the inflammatory process ([@j_hukin-2017-0090_ref_006]) and play a crucial role in cardiovascular disease prevention. EPA and DHA supplementation decreases endothelial activation, improves plaque stability and vascular permeability ([@j_hukin-2017-0090_ref_009]; [@j_hukin-2017-0090_ref_040]; [@j_hukin-2017-0090_ref_039]). The former athletes that were subjected to the Mediterranean diet increased the level of DHA, and improved the basic index related to the fatty acid profile and cardiovascular diseases ([Figure 2](#j_hukin-2017-0090_fig_002){ref-type="fig"}). We did not observe such changes in the CR group.

Subjects who followed the Mediterranean diet and reduced their body mass by more than 3 kg also revealed lower levels of 15-HETE, which is an enzymatic product of arachidonic acid oxidation. The increased production of 15-HETE has been confirmed in the process of atherosclerosis, both in the animal model, as well as in human trials. [@j_hukin-2017-0090_ref_018] conducted a study where rabbits were fed a high cholesterol diet in order to develop atherosclerosis. The study showed that the main metabolite of arachidonic acid during the process of atherosclerosis was 15-HETE ([@j_hukin-2017-0090_ref_018]). 15 HETE is synthesised primarily by macrophages during the process initiated by 15 lipoxygenase (LOX 15) and 12 lipoxygenase (LOX 12). 12 and 15 LOX have the ability to oxidize phospholipids and cholesterol in membranes. The oxidized form of cholesterol esters induces a number of pathological processes which lead to pro-inflammatory cytokine synthesis. 15 HETE increases adhesion of chemokines and adhesion of molecules to the endothelial cells. This process has a significant impact on monocyte circulation, as well as the migration and proliferation of smooth muscle cells. Additionally, 15 HETE activates NADPH oxidase, which is regarded as a key enzyme in the pathogenesis of atherosclerosis ([@j_hukin-2017-0090_ref_013]).

Both the MD and diet based on calorie restriction helped reduce body mass in former athletes. However, it seems that the mechanism of action in both diets was quite different. A CR diet was very effective in the improvement of the lipid profile and reduction of insulin resistance. We observed a significant decrease in crucial biochemical variables after only 6 weeks of the dietary intervention even in subjects with a 2 kg body mass reduction. However, it should be also noted that the 6-week calorie restriction caused unfavourable changes in the fatty acid profile (through lower concentrations of EPA) and did not result in the reduction of inflammation. On the other hand, our study indicates that even a short term MD can improve these variables ([Figure 2](#j_hukin-2017-0090_fig_002){ref-type="fig"}). According to previous research, the Mediterranean diet has a special cardio-protective effect, which was confirmed by our study ([@j_hukin-2017-0090_ref_033]).

Programming optimal nutrition plans for former athletes is a very difficult issue because of great diversity in the exercise metabolism of particular sport disciplines and different anthropometric characteristics. We can conclude that calorie restriction is a healthy solution for former athletes. Even a short period of a calorie restriction diet can significantly improve most basic biochemical variables. The novel aspect of our research includes the finding that calorie restriction diets contain an insufficient amount of omega 3 and 6 fatty acids. For practical implications, we can suggest that former athletes and other subjects following the calorie restriction diet should consider omega -- 3 fatty acid supplementation, especially EPA and DHA, to reduce inflammatory processes and prevent cardiovascular diseases.
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